Clinical outcomes of patients with multiple sclerosis treated with ocrelizumab in a US community MS center: an observational study.
- DOI
- 10.1136/bmjno-2020-000108
- Published
- 2021
- Container
- BMJ neurology open
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1136/bmjno-2020-000108,
title = {Clinical outcomes of patients with multiple sclerosis treated with ocrelizumab in a US community MS center: an observational study.},
author = {Smoot K and Chen C and Stuchiner T and Lucas L and Grote L and Cohan S},
year = {2021},
journal = {BMJ neurology open},
doi = {10.1136/bmjno-2020-000108},
url = {https://doi.org/10.1136/bmjno-2020-000108}
}RIS
TY - JOUR TI - Clinical outcomes of patients with multiple sclerosis treated with ocrelizumab in a US community MS center: an observational study. AU - Smoot K AU - Chen C AU - Stuchiner T AU - Lucas L AU - Grote L AU - Cohan S PY - 2021 JO - BMJ neurology open DO - 10.1136/bmjno-2020-000108 UR - https://doi.org/10.1136/bmjno-2020-000108 ER -
APA
K, S., C, C., T, S., L, L., L, G., & S, C. (2021). Clinical outcomes of patients with multiple sclerosis treated with ocrelizumab in a US community MS center: an observational study.. BMJ neurology open. https://doi.org/10.1136/bmjno-2020-000108
Source records
- pubmed · retrieved 2026-09-26T07:59:39.768Z